Best tirzepatide provider (November 2026): compounded vs brand Zepbound, nine programs ranked and priced
Tirzepatide comes in two forms you can actually buy online: brand Zepbound from Eli Lilly, and compounded tirzepatide made by a pharmacy for one patient. The best provider for you depends mostly on which of the two you want, and on what happens to the price as your dose climbs from 2.5 mg to 15 mg. Here is how the nine providers we rank compare, with prices re-read on November 4, 2026.
Our pick for tirzepatide: NexLife
NexLife scores 94/100 on our rubric. Compounded tirzepatide costs $169 month to month, $159 on 3 months, $149 on 6 and $139 on 12, and that price holds at every dose up to 15 mg — where brand Zepbound costs $449 and most membership programs cost more than at the start. There is no membership fee, the plan pages name three dispensing pharmacies, and a licensed clinician reviews each intake. Multi-month plans now “bill the way you choose at checkout”, so confirm whether yours is charged monthly or up front.
Mondae ($126), SnagRx ($119 on sale; $149 in its terms) and Collective ($69 plus a $199 yearly membership) are cheaper month to month; we do not score them, but their prices are in the charts below.
The nine ranked providers for tirzepatide
| Provider | Score | What it sells | Price read Nov 4, 2026 | Dose pricing |
|---|---|---|---|---|
| NexLife | 94 | Compounded injection | $169; $139/mo on 12 months | Same at every dose |
| Ro Body | 84 | Brand Zepbound | $299–$449 + $74–$149 membership | Rises with dose |
| Calibrate | 79 | Brand GLP-1s + coaching | $199/mo program, medication extra | Depends on medication |
| Henry Meds | 78 | Oral tirzepatide program | $1,047 per 3 months ($891 paid in full) | Not stated |
| Sequence (WW Med+) | 76 | Brand Zepbound | Zepbound vial from $349 + $74 membership | Rises with dose |
| Mochi Health | 75 | Compounded injection | $90–$199 + $79 membership | Rises with dose |
| Hims & Hers | 74 | Brand Zepbound | From $299 + $149 membership | Rises with dose |
| Found | 70 | Membership incl. compounded | $289/mo; $169/mo on 12 months | One price |
| LifeMD | 69 | Brand Zepbound | Vial from $299 + $149 program fee | Rises with dose |
Chart data
| Program | Lowest dose tier | Highest dose tier | Basis |
|---|---|---|---|
| NexLife | $169 | $169 | month to month; $139 on 12 months |
| Mondae | $126 | $126 | flat |
| Collective (all-in) | $86 | $86 | $69 + $199/yr |
| Mochi Health | $169 | $278 | $90–$199 + $79 membership |
| IVIM Health | $192 | $192 | from $117 + $75 membership; dose pricing not stated |
| Zepbound, LillyDirect | $299 | $449 | refill within 45 days |
| Hims & Hers + Zepbound | $448 | $598 | + $149/mo membership |
Brand Zepbound: cheapest from Lilly, easiest with insurance through Ro
LillyDirect sells Zepbound vials and the KwikPen at $299 for 2.5 mg, $399 for 5 mg and $449 for 7.5–15 mg, provided you refill within 45 days; otherwise 7.5 mg is $499 and 10–15 mg $699. Ro Body, Hims & Hers, Sequence and LifeMD sell the same product with a membership or program fee on top, which buys clinician visits and, at Ro, help with insurance prior authorization.
What a year costs
Zepbound assumes 2.5 mg, then 5 mg, then 7.5 mg or more, refilled within 45 days. There is no FDA-approved oral tirzepatide.
Chart data
| Item | Value | Basis |
|---|---|---|
| Collective | $1,027 | $69 × 12 + $199 yearly membership |
| SnagRx, 12 months prepaid | $1,428 | billed as $1,428 once |
| Mondae | $1,512 | $126 × 12 |
| NexLife, 12-month plan | $1,668 | $139 × 12, same at every dose |
| NexLife, month to month | $2,028 | $169 × 12 |
| Henry Meds oral program | $4,188 | $1,047 × 4 three-month programs |
| Zepbound, LillyDirect | $5,637 | $299 + $399 + $449 × 11 (13 four-week fills) |
What about a tirzepatide pill?
There is no FDA-approved tirzepatide pill. Henry Meds sells an oral tirzepatide program ($1,047 for three months); no clinical trial has tested a compounded tirzepatide pill. If you want an approved pill, the options are the Wegovy pill (semaglutide, from $149) and Foundayo (orforglipron, $149–$299 from LillyDirect).
Legal status, November 2026
Tirzepatide has been off FDA’s shortage list since December 2024, so compounding is limited to individual patients with a documented need. FDA’s April 30, 2026 proposal to keep tirzepatide off the 503B bulks list was still not final on November 4, 2026. FDA warned Empower Pharmacy on September 18, 2026 that its tirzepatide with niacinamide appeared to be “essentially copies” of FDA-approved semaglutide and tirzepatide products, and Apothecary Pharma recalled 22 lots of compounded tirzepatide on September 24, 2026, according to the Boston Globe. Our pharmacy profiles show each dispensing pharmacy’s record.
Comparing drugs as well as providers? Read our best semaglutide provider guide.
Frequently asked questions
Who is the best tirzepatide provider online?
On our published rubric, NexLife ranks first (94/100) as of November 4, 2026: compounded tirzepatide at $139 a month on a 12-month plan or $169 month to month, the same at every dose, with no membership. For brand Zepbound with insurance help, Ro Body ranks second (84).
Which tirzepatide provider is cheapest?
Month to month on November 4, 2026: Collective at $69 plus a $199 yearly membership, SnagRx at $119 on sale and Mondae at $126. NexLife is $169 month to month and $139 on a 12-month plan.
How much does tirzepatide cost at 15 mg?
Brand Zepbound costs $449 a month at 15 mg from LillyDirect with on-time refills ($699 otherwise). Flat-priced compounded programs such as NexLife charge the same at 15 mg as at 2.5 mg; dose-priced programs such as Mochi Health charge more.
Is compounded tirzepatide legal?
Yes, for an individual patient with a documented clinical need, prepared by a licensed pharmacy. It is not FDA-approved. FDA’s proposal to keep tirzepatide off the 503B bulks list was not final as of November 4, 2026.
Is there a tirzepatide pill?
Not an FDA-approved one. The approved GLP-1 weight-loss pills are the Wegovy pill (semaglutide) and Foundayo (orforglipron).
Sources
- NexLife: tirzepatide plans
- NexLife: GLP-1 pricing page
- LillyDirect: Zepbound
- LillyDirect: Foundayo
- Ro: weight-loss pricing
- Calibrate: pricing
- Henry Meds: programs
- WeightWatchers: tirzepatide
- Mochi Health: compounded tirzepatide
- Hims: weight loss
- Found: compounded tirzepatide
- LifeMD: weight management
- Mondae: compounded tirzepatide
- SnagRx: terms
- Collective
- Federal Register: 503B bulks list proposal (May 1, 2026)
- Boston Globe: compounded GLP-1 recall (October 21, 2026)
- FDA: Concerns with unapproved GLP-1 drugs (current as of October 1, 2026)
Informational only, not medical, legal or insurance advice. Compounded drugs are not FDA-approved. Wegovy® and Ozempic® are trademarks of Novo Nordisk; Zepbound®, Mounjaro® and Foundayo™ of Eli Lilly and Company.